In vitro modifications of red cell acetylcholinesterase activity.
D000017:ABO Blood-Group System; D000110:Acetylcholinesterase / Q000097:blood*; D000371:Agglutination; D000744:Anemia, Hemolytic, Autoimmune / Q000201:enzymology; D000900:Anti-Bacterial Agents / Q000494:pharmacology; D001896:Boron Compounds / Q000494:pharmacology; D002462:Cell Membrane / Q000201:enzymology; D002800:Cholinesterase Inhibitors; D003545:Cysteine / Q000494:pharmacology; D004798:Enzymes / Q000494:pharmacology; D004899:Erythroblastosis, Fetal / Q000201:enzymology; D004912:Erythrocytes / Q000201:enzymology*; D005260:Female; D006457:Hemoglobinuria, Paroxysmal / Q000201:enzymology; D006801:Humans; D066298:In Vitro Techniques; D009578:Nitrobenzenes / Q000494:pharmacology; D010406:Penicillins / Q000494:pharmacology; D011247:Pregnancy; D013439:Sulfhydryl Reagents / Q000494:pharmacology; D013634:Tannins / Q000494:pharmacology; D014357:Trypsin / Q000494:pharmacology
D000017:ABO Blood-Group System; D000900:Anti-Bacterial Agents; D001896:Boron Compounds; D002800:Cholinesterase Inhibitors; D004798:Enzymes; D009578:Nitrobenzenes; D010406:Penicillins; D013439:Sulfhydryl Reagents; D013634:Tannins; D000110:Acetylcholinesterase; D014357:Trypsin; D003545:Cysteine